Days
Hours
Minutes
Seconds
March 1 & 2, 2024
About
Desert Liver Retreat
We provide a superior scientific program and a fun opportunity to network with colleagues seeking an update in state-of-the-art liver disease care. Our exhibitors are chosen as excellent providers of important products and services to our community.
Target Audience
This event is intended for MDs, DOs, PAs, NPs, RNs, residents, fellows, and clinical research personnel who are involved in the care of patients with liver disease.
Educational Objectives
After attending this event the participant should be better able to:
Utilize most recent guidelines for screening and diagnosing patients at risk of chronic liver disease
Develop an evidence-based treatment regimen for chronic liver disease using latest clinical evidence
Communicate disease and treatment options to patients
Recognize and communicate risks and benefits of therapy
Recognize differential diagnosis for NAFLD & NASH
Characterize risk factors for PBC & be able to discuss different therapies for PBC
Identify diagnostic approaches for HCC and treatment options
Explain diagnostic criteria and diagnostic tools for minimal and overt HE
Define diagnostic and therapeutic strategies for HCC
Demonstrate understanding of the diagnostic approaches for PSC and the role of liver biopsy as well as what therapies are used for PSC and when
Demonstrate understanding of different currently available treatment options for different clinical manifestations of portal hypertension
Choose different interventions and treatment approaches to minimize inpatient health care utilization for patients with liver disease
Describe the hepatic manifestations of COVID-19 infections including acute hepatic injury and cholangitis
2023 - Jointly provided by Postgraduate Institute for Medicine and Pinnacle Clinical Research, PLLC.
Educational grant support is pending and any confirmed support received will be disclosed in future course materials.
Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Arizona Liver Health, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Educational grant support is pending and any confirmed support received will be disclosed in future course material.
Physician Assistant Continuing Medical Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 7 CME credits for activities planned in accordance with AAPA CME Criteria.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 7.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Heather Walters prior to the live event at 214.536.1919.
2023 Agenda
7:00 AM - 8:30 AM
Registration, Breakfast, Exhibits in Foyer
7:30 AM - 8:30 AM
Independently Sponsored Event
Intercept Pharmaceuticals
8:30 AM - 8:35 AM
Opening Remarks
SESSION ONE
Moderator: Naim Alkhouri, MD, FAASLD
Panelists: Amit Singal, MD, MS, FAASLD
Richard Finn, MD
Richard Manch, MD, FAASLD, FACP, FACG
8:35 AM - 9:00 AM
Early Detection of HCC: New Frontiers
Amit Singal, MD, MS, FAASLD
9:00 AM - 9:25 AM
Update on Systemic HCC and Cholangiocarcinoma Rx
Richard Finn, MD
9:25 AM - 9:50 AM
Benign Liver Lesions
Richard Manch, MD, FAASLD, FACP, FACG
9:50 AM - 10:15 AM
Panel Discussion
10:15 AM - 10:30 AM
Break & Exhibits in Foyer
SESSION TWO
Moderator: Naim Alkhouri, MD, FAALSD
Panelists: Jinendra Satiya, MD
Mazen Noureddin, MD, MHSc
Stephen Harrison, MD, FACP, FAASLD
Samuel Klein, MD
10:30 AM - 10:55 AM
NAFLD Diagnosis From A-Z: Everything the PCP and Specialist Should Know
Mazen Noureddin, MD, MHSc
10:55 AM - 11:20 AM
NAFLD Management: Available Options Today and by the End of 2023
Naim Alkhouri, MD, FAASLD
11:20 AM - 11:45 AM
Looking into the Crystal Ball: The Future of NAFLD Treatment
Stephen Harrison, MD, FACP, FAASLD
11:45 AM - 12:15 PM
Obesity Management in the Context of NAFLD
Samuel Klein, MD
12:15 PM - 12:30 PM
Panel Discussion
12:30 pm - 1:30 pm
Independently Sponsored Event
Madrigal Pharmaceuticals
12:30 PM - 1:45 PM
Lunch & Exhibits in Foyer
SESSION THREE
Moderator: Anita Kohli, MD
Panelists: Robert Gish, MD, FAASLD,
Marcelo Kugelmas, MD, FAASLD, FACP,
Naim Alkhouri, MD, FAASLD
1:45 PM - 2:10 PM
Testing & Treatment for HBV/HDV
Robert Gish, MD, FAASLD
2:10 PM - 2:35 PM
HCV Update: Screening and Therapy
Anita Kohli, MD
2:35 PM - 3:00 PM
PBC & PSC: Epidemiology and Treatment
Marcelo Kugelmas, MD, FAASLD, FACP
3:00 PM - 3:25 PM
Pediatric Liver Disease for the Adult Medical Provider
Naim Alkhouri, MD, FAASLD
3:25 PM - 3:35 PM
Panel Discussion
3:35 PM - 3:50 PM
Break & Exhibits in Foyer
SESSION FOUR
Moderator: Jacqueline O'Leary, MD, MPH
Panelists: Jasmohan Bajaj, MD, FAASLD
Toufic Kachaamy, MD
3:50 PM - 4:15 PM
Preventing Complications in Cirrhosis
Jacqueline O'Leary, MD, MPH
4:15 PM - 4:40 PM
The Microbiome in Cirrhosis
Jasmohan Bajaj, MD, MS, FAASLD, FACG, AGAF
4:40 PM- 5:05 PM
Endo-Hepatology: A New Frontier
Toufic Kachaamy, MD, FASGE, AGAF
5:05 PM - 5:20 PM
Panel Discussion
5:20 PM - 5:25 PM
Independently Sponsored Event
Perspectum LiverMultiScan
5:25 PM - 5:30 PM
Concluding Remarks
Reception to Follow for Registered Attendees and Sponsors
Course Directors
2023 Desert Liver Conference Faculty
2023 Fees
Registration Fees
Early Bird Before 12/30
Regular After 12/30
In-person attendance (includes CME/MOC) ++ may be subject to facility and service fees
$125++
$150++
In-person attendance, CEU, non-CME (nurses, fellows/students, and others not requesting CME credits, research personnel) ++ may be subject to facility and service fees
$75++
$100++
Virtual attendance (includes CME and non-CME) ++ may be subject to facility and service fees
$100++
$125++
Thank You 2023 Diamond Sponsors
Thank You 2023 Top Sponsor
Thank You 2023 Platinum Sponsors
Thank You 2023 Gold Sponsor
Thank You 2023 Silver Sponsors
